Verva Reports Passing of Verva Director Dr. Andrew Rainsford Baker

Melbourne, Australia (23 March, 2012).  Verva Pharmaceuticals Ltd. regretfully reports the recent passing of Verva Director Dr. Andrew Baker after a battle with cancer.  Andrew was 50 years old.  He is survived by his wife Nancy, son Sam and daughter Clare.

Andrew was a Partner at GBS Venture Partners and one of Verva’s founding Directors.  Andrew drew on his extensive international industry experience (including work with industry leaders Genentech, Bayer and Johnson & Johnson) to provide essential guidance and strategic advice in advancing Verva’s corporate and product development programs.

Verva CEO Vince Wacher stated: “We are very saddened by Andrew’s untimely loss and express our heartfelt condolences to his family.”

A Memorial Service for Andrew will be held at St. Leonards Uniting Church, 2 Wolseley Ave, Brighton, Victoria on Monday 26 March 26, 2012 at 1.30 p.m.  In lieu of flowers, donations to the Australasian Sarcoma Study Group would be greatly appreciated.  http://www.australiansarcomagroup.org/support-sarcoma-research.html.  Please note Andrew Baker as the bequest.

Andrew’s seat on the Verva board will be assumed by Dr. Steve Gourlay, also a Partner at GBS Venture Partners.